PANCE - pulm review Flashcards

1
Q

when is the newborn screen for CF done

A

24-48 hrs after 1st feed

ALL neonates w meconium ileus should be evaluated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

tx for CF

A

clear airway secretions:
- chest physiotherapy
- HYPER-tonic saline

dornase alpha:
- mucolytic

ivacaftor:
- CFTR modulator that increases chloride transport

pancreatic enzyme replacement and fat soluble vitamins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

patho of chronic bronchitis

A

overproduction and hypersecretion of mucus by goblet cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

definition of chronic bronchitis

A

chronic productive cough for at least 3 mo out of the yr for at least 2 consecutive yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the DLCL in chronic bronchitis

A

NORMAL DLCL
*how to differentiate from emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the DLCL in emphysema

A

DECREASED DLCL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how to dx chronic bronchitis

A

PFT
- decreased FEV1/FVC <70%
- NORMAL DLCL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

hemoglobin in chronic bronchitis

A

increased hemoglobin and hematocrit
-due to chronic hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2 things that improve mortality rate in COPD

A

oxygen therapy and smoking cessation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

only use oxygen in COPD IF

A

O2 sat is < 88%

OR

PaO2 < 55%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

COPD Group A definition

A

minimal symptoms and infreq exacerbations

tx: SABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

COPD Group B definition

A

more severe symptoms, but infreq exacerbations

tx:
SABA + LABA (salmeterol)
or
SABA + LAMA (tiotropium)
*LAMA’s are preferred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

COPD Group C definition

A

minimal symptoms, but freq exacerbations

tx: same as group B
SABA + LAMA
or
SABA + LABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

COPD Group D definition

A

severe symptoms and freq exacerbations

tx:
SABA + LABA + LAMA
or
SABA + LABA + inhaled CS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

acute COPD exacerbation tx

A

macrolides (azithro)

SABA + ipratropium as breathing tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

emphysema patho

A

enlarged air spaces due to alveolar septae destruction

*structural changes occur distal to terminal bronchioles

17
Q

centrilobular emphysema

A

MC in smokes

affects UPPER lobes

18
Q

panacinar emphysema

A

MC in alpha-1 antitrypsin def

affects LOWER lobes

*A1 sauce in the PAN

19
Q

CXR findings in emphysema

A
  • flattened diaphragm
  • bullae > 1cm
  • hyperinflation
  • small-thin heart
20
Q

ABG of PE

A

respiratory alkalosis

21
Q

what is the westermark sign or hampton hump

A

triangular or rounded pleural based infiltrate adjacent to hilum

seen in PE

22
Q

tx of PE

A

anticoagulation for 3 mo MINIMUM

heparin, followed by rivaroxaban after acute phase

23
Q

CXR findings of asbestosis

A
  • interstitial fibrosis
  • pleural thickening
  • calcified pleural plaques* (on diaphragm or lateral chest wall)
24
Q

CXR findings of silicosis

A
  • calcification of hilar nodes
    “eggshell calcifications”
25
Q

how to dx pneumoconiosis

A

PFT
- restrictive pattern w reduced diffusing capacity
*FEV1/FVC >80% or decreased FVC

26
Q

CT findings for idiopathic pulmonary fibrosis

A
  • diffuse patchy fibrosis w pleural based honeycombing
  • ground glass opacities on fine reticular pattern
27
Q

tx for idiopathic pulmonary fibrosis

A

antifibrotic drugs:
- pirfenidone
- nintedanib

oxygen therapy

lung transplant

28
Q

patho of sarcoidosis

A

systemic granulomatous dz characterized by NON-caseating granulomas

29
Q

lupus pernio is pathognomonic for what condition

A

sarcoidosis

violaceous plaques on cheeks, nose, and eyes

30
Q
A